<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996824</url>
  </required_header>
  <id_info>
    <org_study_id>2017-081</org_study_id>
    <nct_id>NCT03996824</nct_id>
  </id_info>
  <brief_title>Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy</brief_title>
  <acronym>TREATGENE</acronym>
  <official_title>Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Pasteur</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Pasteur</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gene therapy is a promising strategy to treat hearing loss and vestibular disorders, and
      Associated adenovirus (AAV) is shown as a good viral vector for inner ear therapy in animal
      models.

      This study aims to study in vitro viral transduction of AAV in human inner ear cells,
      collected during non-conservative surgeries for vestibular schwannoma.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 19, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AAV transduction in inner ear cells</measure>
    <time_frame>10 days</time_frame>
    <description>The transduction will be measured with immunostaining techniques</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hearing Loss, Sensorineural</condition>
  <arm_group>
    <arm_group_label>AAV viral transduction</arm_group_label>
    <description>Collection of inner ear cells during a non-conservative surgical approach (translabyrinthine or transotic).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Peroperative collect of inner ear cells</intervention_name>
    <description>After obtaining an informed consent during the preoperative medical visit, and if a non-conservative approach (translabyrinthine or transotic) is decided, the collect of inner ear cells will be performed during surgical approach.
The sample will be collect in a sterile tube, and carried to the laboratory were it will be placed bon cell culture.</description>
    <arm_group_label>AAV viral transduction</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      inner ear cells collected during surgery
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing surgical resection of vestibular schwannoma.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient ≥ 18 years old

          -  Operative indication for a non-conservative resection of vestibular schwannoma,
             decided by the surgeon in accordance with the patient

          -  Informed consent obtained

          -  Patients with a french social protection (AME excluded)

        Exclusion Criteria:

          -  Intravestibular or intra-cochlear extension of the tumor

          -  Pregnant woman

          -  Patient with administrative control

          -  Medical contra-indication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ghizlene Lahlou</last_name>
    <role>Study Director</role>
    <affiliation>Institut Pasteur</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ghizlene Lahlou</last_name>
    <phone>33 1 45688891</phone>
    <email>ghizlene.lahlou@pasteur.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saaid Safieddine</last_name>
    <email>saaid.safieddine@pasteur.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital de Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <state>Ile De France</state>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme Nevoux, MD</last_name>
      <email>jerome.nevoux@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jérôme Nevoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpétrière</name>
      <address>
        <city>Paris</city>
        <state>Ile De France</state>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann Nguyen, MD</last_name>
      <email>yann.nguyen@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Yann Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>July 12, 2019</last_update_submitted>
  <last_update_submitted_qc>July 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

